Lisa Pleyer, Xu Zhang, Manuel Drost, Hubert Angermann, Julia Oberlechner, Michael Pfeilstöcker, Verena Petzer, Sonja Heibl, Jennifer Moritz, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Angelika Pichler, Bernd Hartmann, Gregor Aschauer, Clemens Schmitt, Sonia Vallet, Szilvia Boros, Petra Pichler, Andrea Hammerl-Steiner, Johannes Andel, Jan Philipp Bewersdorf, Amer Zeidan, Daniel Lopes de Menezes, Thomas Prebet, Thomas Melchardt, Richard Greil, Lona Gaugler. "Multivariable-adjusted validation of IWG23-defined peripheral blood complete remission (PB-CR) and IWG23 response criteria in 2,042 patients with MDS, CMML or AML treated with diverse first-line therapies: Insights from the AML-001 trial (NCT01074047) and the ‘austrian myeloid registry’ (NCT04438889) of the AGMT study group." Blood, 2025. doi:10.1182/blood-2025-3859